New Approach to Phospholipidosis Prediction

Information

• Research Project
• 8715281

• ApplicationId

  8715281

• Core Project Number

  R44FD004052

• Full Project Number

  2R44FD004052-02

• Serial Number

  004052

• FOA Number

  PA-13-234

• Sub Project Id

• Project Start Date

  9/1/2011 - 13 years ago

• Project End Date

  8/31/2016 - 8 years ago

• Program Officer Name

• Budget Start Date

  9/1/2014 - 10 years ago

• Budget End Date

  8/31/2016 - 8 years ago

• Fiscal Year

  2014

• Support Year

  02

• Suffix

• Award Notice Date

  9/4/2014 - 10 years ago

Organizations

• Echelon Biosciences, Inc.

DESCRIPTION (provided by applicant): Drug safety is a major concern for pharmaceutical groups, regulatory bodies, basic researchers and particularly patients. Safe and effective drugs maximize successful clinical outcomes and patient compliance. This project will provide unique tools for detecting drugs that have potential to induce the dangerous outcome phospholipidosis early in the drug development process and will identify patients that may be susceptible to this dangerous adverse event.

IC Name

• Activity

  R44

• Administering IC

  FD

• Application Type

  2

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  449426

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  FDA:449426\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  ECHELON BIOSCIENCES, INC.

• Organization Department

• Organization DUNS

  179151188

• Organization City

  SALT LAKE CITY

• Organization State

  UT

• Organization Country

  UNITED STATES

• Organization Zip Code

  841081228

• Organization District

  UNITED STATES